GENFIT

What this means for you

Registered since 27 Jul 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Jul 2024).

Record

Serial number

76365742

Registration number

2865973

Mark type

Word mark

Filed

31 Jan 2002

Published for opposition

04 May 2004

Registered

27 Jul 2004

Next maintenance due

27 Jul 2024

Attorney of record

Ronald M. Kachmarik

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of cardiovascular diseases, dermatological diseases, metabolic disorders, inflammatory disorders, skin and mucosal disorders, disorders in the central nervous system, infections, cancers and oncological disorders, immunodeficiency and immunologic disorders, asthma, allergies, lipidic disorders, obesity and diabetes;[ veterinary pharmaceutical preparations for use in the treatment of cardiovascular diseases, dermatological diseases, metabolic disorders, inflammatory disorders, skin and mucosal disorders, disorders in the central nervous system, cancers, and oncological disorders, immunodeficiency and immunologic disorders, asthma, allergies, lipidic disorders, obesity and diabetes; sanitary preparations for diagnosis and for acute and chronic care, namely, antibiotic, antibacterial, antiviral and antifungal agents for elimination or reduction of germs, bacteria, viruses and fungi;] chemical preparations for medical, pharmaceutical or[ veterinary] diagnostic use; enzymatic preparations for medical, pharmaceutical [or veterinary] use; biological preparations, namely, antibodies and fragments of antibodies for laboratories, diagnostics, and analytics for human[ and veterinary] medical diagnostic use; pharmaceutical preparations for the treatment of skin conditions, [medicated skin care preparation for pharmaceutical use; medicated sunburn preventing products, namely, creams, oils, lotions, gels, for pharmaceutical use; slimming medical preparations;] cultures of microorganisms for medical, pharmaceutical [and veterinary ]use; media for bacteriological cultures; nutrients for use in medical, pharmaceutical [and veterinary research;] cell preparations for medical, pharmaceutical [or veterinary use,] in particular for gene therapy and cell therapy; [kits consisting primarily of culture media, culture boxes, culture additives, and diagnostic reagents for the preparation of cells or for the selection of biologically active compounds for medical, pharmaceutical or veterinary laboratory testing, or for medical or veterinary diagnostic use; diagnostic and biological preparations and cultures of microorganisms and cells for clinical or medical laboratory use; reagents for medical, veterinary and diagnostic use, diagnosis products, namely,] reagents for medical [or veterinary use;] chemical and biological reagents for clinical or medical laboratory use;[ diagnostic preparations for clinical or medical laboratory use;] diagnosis reagents for medical[, veterinary] use[ and in vitro use in biochemistry,] clinical chemistry and microbiology[; dietetic substances, namely, dietary supplements and food supplements for medical use; dietetic foodstuffs adapted for medical use]
• Class 042 — Scientific and technological services: Pharmaceutical research and development of new drug products for others; scientific, biological and medical research in the fields of pharmacology, analytical chemistry, biochemistry, immunology, genetic, medicinal chemistry, drug development of new drug products for others; scientific, biological and medical research in the field of pharmacology, analytical chemistry, biological and medical research in the field of pharmacology, analytical chemistry, biochemistry, immunology, genetic, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology, chemical, biochemical and biotechnological analysis; basic and applied scientific research; technical research, namely screening and selection of molecules; validation of biological targets; development and validation of biological tests, cell tests, and genetic tests, identifying, characterizing, validating, and development biologically active molecules through the se of functional genomics; analysis of biological substances in biological fluids; technical consultation in the field of pharmaceuticals; legal services in the field of scientific research, medical sciences and intellectual property rights; patent agency and licensing; computer programming in the field of scientific research, medical sciences and intellectual property rights; patent agency and licensing; computer programming in the field of scientific research and for the pharmaceutical industry; surveying and engineering; chemical analysis in the field of pharmacology; technical consultation in the field of pharmacology; consultation, not connected with the conduct of business, in the fields of scientific research and therapy; research and development of new pharmaceutical products for third parties; providing an online electronic computer database in the field of scientific information
• Class 044 — Medical, beauty and agricultural services: Providing an online electronic computer database in the field of medical and pharmaceutical information

Owner

• GENFIT, Loos, FR
• GENFIT, Loos, FR
• GENFIT, Loos, FR

Prosecution history

• 29 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 29 Mar 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
• 29 Mar 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 29 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 06 Nov 2023 — TEAS SECTION 8 & 9 RECEIVED
• 27 Jul 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 16 Sept 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 16 Sept 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 16 Sept 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 13 Aug 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 25 Jul 2014 — TEAS SECTION 8 & 9 RECEIVED
• 13 Aug 2010 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 11 Aug 2010 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 22 Jul 2010 — TEAS SECTION 8 & 15 RECEIVED
• 20 Feb 2009 — REVIEW OF CORRESPONDENCE COMPLETE